Where to go next with neuroprotection in multiple sclerosis?

Lancet Neurol. 2010 Jul;9(7):647-8. doi: 10.1016/S1474-4422(10)70133-2. Epub 2010 Jun 8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cerebral Infarction / drug therapy*
  • Cerebral Infarction / etiology
  • Humans
  • Movement Disorders / drug therapy
  • Movement Disorders / etiology
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy*
  • Neuroprotective Agents / therapeutic use*

Substances

  • Neuroprotective Agents